Laboratorio Reig Jofre, S.A. (FRA:FEQ1)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Sale of nutritional supplements	59.25M	59.90M	54.15M	47.02M	42.25M
Sale of nutritional supplements Growth	-1.08%	10.62%	15.16%	11.29%	5.93%
Sale of Pharmaceutical Products	263.05M	244.15M	217.00M	189.21M	187.83M
Sale of Pharmaceutical Products Growth	7.74%	12.51%	14.69%	0.74%	17.16%
Provision of Services	16.59M	12.04M	-	-	-
Provision of Services Growth	37.82%	-	-	-	-
Total	338.90M	316.09M	271.15M	236.23M	230.08M
Total Growth	7.22%	16.57%	14.78%	2.67%	14.92%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Rest of Europe	27.57M	22.28M	16.73M	13.27M	12.54M
Rest of Europe Growth	23.78%	33.15%	26.09%	5.82%	390.15%
Asia	24.43M	25.52M	15.67M	16.83M	13.85M
Asia Growth	-4.29%	62.90%	-6.92%	21.52%	21.26%
Spain	140.37M	141.06M	118.56M	105.53M	104.06M
Spain Growth	-0.49%	18.98%	12.34%	1.41%	15.38%
European Union	132.39M	115.47M	110.43M	88.14M	84.92M
European Union Growth	14.66%	4.56%	25.29%	3.79%	-3.10%
Africa	5.85M	5.18M	4.38M	7.53M	10.36M
Africa Growth	12.89%	18.44%	-41.90%	-27.27%	167.30%
America	6.62M	4.26M	3.38M	3.18M	2.52M
America Growth	55.46%	26.07%	6.22%	26.32%	1.82%
Oceania	1.65M	2.32M	2.01M	1.75M	1.84M
Oceania Growth	-28.63%	15.34%	14.74%	-4.68%	-10.53%
Total	338.90M	316.09M	271.15M	236.23M	230.08M
Total Growth	7.22%	16.57%	14.78%	2.67%	14.92%

Source: S&P Global Market Intelligence.